Background & Aims Magnetic resonance imaging proton density fat fraction (MRI-PDFF)
offers promise as a non-invasive biomarker of treatment response in early-phase …

Non-alcoholic fatty liver disease (NAFLD) has become one of the most prominent forms of
chronic liver disease worldwide, reflecting the epidemic of global obesity. Those with the …

Objective To describe liver disease related mortality in the United States during 1999-2016
by age group, sex, race, cause of liver disease, and geographic region. Design …

Background & Aims Although hepatitis B and C have been the main drivers of hepatocellular
carcinoma (HCC), nonalcoholic steatohepatitis (NASH) has recently become an important …

Background & Aims Increased levels of galectin 3 have been associated with nonalcoholic
steatohepatitis (NASH) and contribute to toxin-induced liver fibrosis in mice. GR-MD-02 …

Background and Aims Patients with cirrhosis are at increased risk of postoperative mortality.
Currently available tools to predict postoperative risk are suboptimally calibrated and do not …

Background & Aims Emricasan, an oral pan-caspase inhibitor, decreased portal pressure in
experimental cirrhosis and in an open-label study in patients with cirrhosis and severe portal …

Comment e810 www. thelancet. com/hiv Vol 6 December 2019 led to an increase in people
living with HIV from 8· 74 million in 1990 to 36· 82 million in 2017. Young adults remain at …

Cirrhosis is the common end stage of a number of chronic liver conditions and a significant
cause of morbidity and mortality. With the growing epidemic of obesity and metabolic …

Background Tumour growth patterns have important implications for surveillance intervals,
prognostication and treatment decisions but have not been well described for hepatocellular …